Fundraising Fox
/Companies
Sign in

Scoop

YC F25

San Francisco, US · Founded 2025 · 2 employees · 5 known investors

Find your way into Scoop

Each arrow is one introduction. Sign up to fill in the first one.

11,424 people can intro you to Jay

Ask Garry Tan to introduce you to Jay Kwon

You →Garry · together at YC F25 →Jay

10,556 people can intro you to Vincent

Ask Jamie Chen to introduce you to Vincent Park

You →Jamie · together at Bedrock Analytics →Vincent

Sign up to find every way you can get introduced to Scoop

  • Your email: who you already know at Scoop, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Scoop team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Scoop converts scientific and manufacturing data into dynamic regulatory documents for drug submissions, using AI to continuously reconcile updates and maintain consistency across filings for pharmaceutical companies and regulatory teams.

AI & Machine LearningBiotechEnterprise SoftwareMedical DevicesArtificial IntelligenceB2BComplianceBiotechnologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (F25)

Scoop was founded in 2025 by Vincent Park and Jay Kwon.

VPVincent Park
Vincent ParkFounderHe previously held roles at Persona and Dropbox.
JKJay Kwon
Jay KwonFounderJay Kwon is co-founder and CTO of Scoop, with prior experience in applied AI at Google Search, including work on Gemini chain-of-thought reasoning. He has supported clinical trial design for ALS therapeutics at Corestem and worked previously at Genentech and CJ Bioscience. He holds an MS in Computer Science and Biotechnology from Penn.

Investors · 5

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

ACTIVATE CAPITAL PARTNERSreportedSan Francisco · $10M – $30M

How we know: funding news · Not right? Tell us

East VenturesreportedSingapore · $15M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Index VenturesreportedSan Francisco · $540K – $10.8M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

Evolvere BioSciencesEvolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.
Paceline BioPlay Health builds a clinical decision-support platform for healthcare providers to deliver personalized menopause and women's health care. The platform serves primary care physicians and other providers treating women navigating perimenopause and menopause.
Sensible BiotechnologiesSensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development. The platform addresses limitations of synthetic mRNA by enabling design-based biology approaches.
SFA TherapeuticsSFA Therapeutics develops oral therapeutic candidates based on deuterated short-chain fatty acids to treat autoimmune and oncologic diseases. The company's lead program, SFA-002, is in Phase 2 development for plaque psoriasis, with additional pipeline assets targeting pancreatic cancer, liver cancer, rheumatoid arthritis, and inflammatory bowel disease.
AlixiaAlixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.

Companies working in the same space as Scoop.

In the news

Scoop: AI agents that speed up drug trials, starting with IND filingsycombinator.com · Nov 2025

Frequently asked questions

What does Scoop do?
Scoop converts scientific and manufacturing data into dynamic regulatory documents for drug submissions, using AI to continuously reconcile updates and maintain consistency across filings for pharmaceutical companies and regulatory teams.
Who founded Scoop?
Scoop was founded by Vincent Park, Jay Kwon in 2025.
Who are Scoop's investors?
Scoop's investors include NGP Capital, Y Combinator, ACTIVATE CAPITAL PARTNERS, East Ventures, Index Ventures.
Where is Scoop headquartered?
Scoop is headquartered in San Francisco, US.